---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-004786"
form_type: "8-K"
ticker: null
cik: "0001792581"
company_name: "Kiromic Biopharma, Inc."
filed_at: "2024-04-05T23:59:59+00:00"
generated_at: "2026-06-04T01:54:05.864457+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kiromic BioPharma issues $2M senior secured convertible note at 25%, convertible at $2.50

## Summary
- Issued $2,000,000 25% Senior Secured Convertible Promissory Note to an accredited investor.
- Note matures April 2, 2025; interest rate 25% (27% upon default).
- Initial conversion price $2.50 per share, with 19.99% beneficial ownership limitation.
- Note secured by all fixtures, equipment, and intellectual property of the company.

## SEC filing metadata
- accession: 0001558370-24-004786
- form_type: 8-K
- cik: 0001792581
- company_name: Kiromic Biopharma, Inc.
- filed_at: 2024-04-05T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792581/000155837024004786/0001558370-24-004786-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792581/000155837024004786/krbp-20240402x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-004786
- JSON: https://secwatch.observer/filing/0001558370-24-004786.json
- Plain text: https://secwatch.observer/filing/0001558370-24-004786.txt

## Key facts
- Material Agreements
  Kiromic Biopharma, Inc. entered into 25% Senior Secured Convertible Promissory Note with an accredited investor valued at principal amount $2,000,000; 25% interest per annum; convertible at $2.50 per share (effective 2024-04-02).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: an accredited investor
  - Value: principal amount $2,000,000; 25% interest per annum; convertible at $2.50 per share
  - Effective: 2024-04-02
  source text: On April 2, 2024, Kiromic BioPharma, Inc. (the “Company”) issued a 25% Senior Secured Convertible Promissory Note (the “Note”) to an accredited investor.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792581/000155837024004786/0001558370-24-004786-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.